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Abstract The present study describes a significant amino acid 
sequence homology between neuronal Cdk5 activator (nck5a) and 
an open reading frame of an unknown gene on the yeast S. 
cerevisiae chromosome III. A cDNA encoding a 25 kDa fragment 
of this yeast protein, the region containing homologous sequence 
to nck5a was cloned and expresed in E. coli as a glutathine-s- 
transferase fusion protein (GST-p25Y). GST-p25Y was found to 
block the in vitro activation of Cdk5 by nck5a and to affinity 
precipitate Cdk5 from bovine brain extract. The observations 
indicate that the yeast protein is capable of specific and high 
affinity association with Cdk5. 
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1. Introduction 
Mammalian brains contain a Cdc2-like kinase [ 1,2], called 
neuronal CdQ-like kinase (Nclk). Nclk is composed of Cdk5, 
the catalytic subunit and a 25 kDa regulatory subunit. This 25 
kDa regulatory subunit is essential for the kinase activity [3,4] 
and has been indicated to be a proteolytic derivative of a brain- 
and neuron-specific 35 kDa protein [3,5], named neuronal 
Cdk5 activator (nck5a, or p35/p25nck5a). More recently, an 
isoform of the p35nck5a has been identified and cloned [6], 
named neuronal Cdk5 activator isoform (p39nck5ai). The 
p39nck5ai shows 57% identity to p35nck5a in amino acid se- 
quence [6]. While all of the well-characterized Cdk activators 
belong to cyclin family, p35nck5a and p39nck5ai display no 
overall sequence homology to cyclins except a region of 17 
amino acid residues where it shows a low degree of similarity 
to members of cyclin [3,7]. In addition, although most of the 
cyclin activation of Cdks has been found to depend on the 
action of a Cdk activating kinase (Cak), nck5a and nck5ai 
activation of Cdk5 shows no such dependence on Cak. These 
results suggest that nck5a and its isoform represent a distinct 
type of Cdk activator. 
In the present study, we show that an amoni acid sequence 
deduced from an open reading frame (ORF) of an unknown 
gene on the chromosome III of yeast Saccharonzyces ~~vevi.r& 
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(a hypothetical 143.8 kDa protein in ERSI-TUPl intergenic 
region) [8] contains a region homologous to p35nck5a. A frag- 
ment of 25 kDa recombinant protein encoded by this yeast 
ORF corresponding to the region of 21 kDa functional frag- 
ment of p35nck5a (p2lnck5a) [3,4] was expressed in E. coli and 
further demonstrated to bind Cdk5 with high affinity. The 
results are compatible with the notion that p35nck5a defines a 
new family of kinase activators and suggest that this novel 
protein may represent an activator protein for CdkS-like pro- 
tein kinase in yeast. 
2. Muter& and methods 
2.1. Cloning of‘ the cDNA jxgment of the yeast ORF and constructing 
into the pGEX-2T expression vector 
A cDNA segment encoding residues 636-843 of the ORF was ampli- 
fied from yeast S. cerevisiae genomic DNA library (a gift from Dr. D. 
Young, University of Galcary) by PCR [3] with primers derived from 
the reported yeast hypothetical amino acid sequences [S]. The PCR 
product was inserted into a PCRTMII plasmid vector (Invitrogen, San 
Diego, CA) flanked by EcoRI site on both sides. After EcoRI digestion, 
the cDNA of yeast gene fragment was cloned into an expression plas- 
mid vector pGEX-2T linearized at EcoRI site. This construction en- 
codes a protein composed of a 26 kDa GST fused to the 25 kDa 
fragment of the yeast protein (GST-p25Y). Orientation and transla- 
tional reading frame of this recombinant DNA was confirmed by DNA 
sequencing. 
2.2. Expression and purification of rrcombinunt proteinsfiom E. coli 
The above recombinant plasmid for GST-p25Y, as well as recombi- 
nant plasmids for the 21 kDa fragment of p35nck5a (GST-~21) [3] and 
Cdk5 (GST-Cdk5) [5] were transformed into the E. coli strain 
BL2l(DE3) 191 for expression. Briefly, a freshly transformed bacterial 
colony carry& each of the recombinant plasmid was cultured into two 
liters of LB medium containing 100 ,@pl ampiccillin. When OD,,,,, 
of the bacterial culture reached 0.60.8, the protein expression was 
induced by 0.4-0.8 mM isopropyl-B-o-thiogalactoside (ICTG) at 22°C 
for I6 h (GST-~25Y) or 37°C for 3 h (GST-~21 and GST-Cdk5). The 
bacteria cells \;ere &en harvested and‘fusion proteins expressed were 
affinity purified by glutathione linked agarose (GSH, from Sigma, St. 
Louis, MO, USA) as described previously [3]. 
2.3. Reconstruction of Nclk kinase activity and competition assay 
The in vitro reconstruction of kinase activity by purified GST-p21 
and GST-Cdk5 were carried out as described in [3]. Briefly, 8 pmol of 
GST-p21 or GST were incubated with 2 pmol of GST-Cdk5 in a kinase 
assay buffer at 30°C for 2 h for reconstruction, followed by adding 100 
PM bf histone peptide of the kinase reaction substrate anh 100 ,& of 
r-[“PlATP (400 dnm .mol-‘) incubating at 30°C for 20 min. The kinase 
a&ivLty was quaniitatively measured asthe incorporation of 32P into the 
histone peptide as described previously [l]. For competition assays, 
various amount of GST-p25Y or GST (2,4, 8 and I6 pmol) were mixed 
individually with constant amount of GST-p21 at 8 pmol; or various 
amount of GST-~21 (2.4, 8 and 16 pmol) were mixed individually with 
constant amount of GST-p25Y or GST at 8 pmol, and then perform 
the in vitro reconstruction of kinase activity the same as above. The 
incorporation of ‘*P into the histone peptide was compared with the 
activity without GST-p25Y competition. 
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2.4. Western blot analysis of the GST-~25 Y binding protein from bovine 
brain 
Native monomeric Cdk5 was partially purified from the 120,000 x g 
supernatant of bovine brain extract by Mono-S ion-exchange and Su- 
perose 12 gel filtration as described [l]. The fractions that contain the 
monomeric Cdk5 were pooled and incubated with GST-p25Y or GST 
in 20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM DTT and 2 mM ATP 
at 22°C for 1 h. Buffer equilibrated GSH beads were added into the 
reaction and rotated at 4°C for 1 h to affinity bind with GST. The beads 
were then washed 3 times in the same buffer and 2 times supplemented 
with 0.35 M NaCl. After boiled in SDS polyacrylamid gel electrophore- 
sis (SDS-PAGE) sample buffer, the bound proteins were resolved by 
12% of SDS-PAGE [lo] and were electro-transferred to the Immobilon 
P membrane. The blotted membranes were stained by Coomassie Blue 
R250 or immunostained by specific antibodies raised against a peptide 
of Cdk5 internal sequence (Cdk5 I), a peptide of Cdk5 carbonyl termi- 
nal sequence (Cdk5 C), and the intact bacterial-expressed Cdk5 isolated 
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Fig. 1. Amino acid sequence alignment between p35nck5a and a yeast 
ORF (YORF). (A) Amino acid sequence alignment of p35nck5a and 
the YORF (500-855). The boxed region shows the highest homology 
between these two proteins. The underlined region represents the frag- 
ment that has been cloned and expressed (p25Y) for characterization. 
(B) Sequence comparison of the high homology segment among 
p35nckSa, YORF and members of human cyclin family (A, Bl, B2, E, 
F, Dl, D and C). The residues in the shaded boxes indicate identical 
amino acids in p35nck5a and YORF. The lower arrow heads indicate 
amino acids in YORF which are also conserved in members of the 
human cyclin family. 
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Fig. 2. Competition assay of the GST-Cdk5 activation. (A) The compe- 
tition assay was performed by mixing 2,4,8 and 16 pmol of GST-p25Y 
(open square) or GST (solid square) individually with 8 pmol of GST- 
p21 and reconstituting with 2 pmol of GST-Cdk5. The results are 
plotted as the percentage of phosphate incorporation in the absence of 
GST-p25Y competition. (B) 2 pmol of GST-Cdk5 was activated by 
reconstitution with 2, 4, 8 and 16 pmol of GST-p21 in the absence (+) 
or presence of 8 pmol of GST-p25Y (open square) or GST (solid 
square). The results are plotted as the amount of phosphate incorpora- 
tion (pmol/min). 
3. Results and discussion 
During GenBank searching for proteins similar to p35nck5a, 
the only homologous sequence found was an open reading 
frame from an unknown gene on yeast S. cerevisiae chromo- 
some III. This yeast open reading frame encodes a hypothetical 
143.8 kDa protein of 1226 amino acid residues. Fig. 1A shows 
the alignment of the homologous region between p35nck5a and 
residues 530-851 of the yeast open reading frame. The two 
sequences show 16.3% identity and 42.0% conservation. Al- 
though the overall sequence similarity is not high, a region of 
21 residues (residues 226-246) in p35nck5a displays a signifi- 
cantly higher degree of sequence identity to the corresponding 
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Fig. 3. Western blot analysis of the GST-p25Y binding protein in 
bovine brain. Partially purified bovine brain extract was incubated with 
GST-p25Y (lane 1) or GST (lane 2) at 20°C for 60 min and then affinity 
precipitated by the GSH-agarose beads. The precipitated proteins were 
analyzed along with the native Cdk5 purified from bovine brain (lane 
3). The blots were stained by Coomassie Blue R250 (A) and probed with 
specific antibodies of CdkS-I (B), CdkS-C (C) and the expressed Cdk5 
(D). 
region of the yeast protein (residues 7655790). In this region, 
a 62% identity was observed. Significantly, this region of 
p35nck5a contains most of the 17-residue sequence that is the 
only region displaying some similarity to cyclin sequences (Fig. 
1B). The similarity between p35nck5a and th eyeast ORF in this 
17-residue sequence is higher than that between p35nck5a and 
cyclins and, as shown in Fig. lB, some sequence similarity can 
also be observed between yeast ORF and cyclins in the consen- 
sus region of cyclin box. 
A region of the yeast protein corresponding to the 21 kDa 
functional fragment of p35nck5a was cloned by PCR and ex- 
pressed as GST fusion protein in E. coli (GST-p25Y). Previous 
studies have shown that p2lnck5a and its GST-fusion protein 
can associate with Cdk5 to result in an active histone Hl pep- 
tide kinase, suggesting that this truncated p2lnck5a protein 
contains the kinase activation domain [3,4]. When the GST- 
p25Y was incubated with GST-Cdk5, no kinase activity was 
obtained (results not show), whereas incubation of GST-p21 
with the GST-Cdl<5 resulted the expected kinase activity. 
Although GST-p25Y exhibited no Cdk5 activation activity, 
it could effect the GST-Cdk5 by blocking the kinase activation 
by p2lnck5a. Thus, the activation of a GST-Cdk5 sample by 
8 pmol of GST-p21 could be effectively inhibited by GST-p25Y 
in a dose dependent manner (Fig. 2A). Complete inhibition was 
obtained at 8 pmol or more of GST-p25Y. The control GST 
samples at up to 16 pmol showed little or no inhibition effect 
on the activation of Cdk5 by GST-~21. Same result can also 
be observed when activation of 2 pmol of Cdk5 by 2-16 pmol 
of GST-p21 in the presence of 8 pmol of GST-Cdk5. The 
GST-p21 activation were significantly inhibited by GST-p25Y, 
but not GST (Fig. 2B). The effect of GST-p25Y on Cdk5 
appears to be specific, since the activation of Cdk2 by cyclin 
A, in the presence of Cak, was found not to be effected by 
GST-p25Y (results not shown). 
A plausible suggestion for the observed p25Y inhibition of 
Cdk5 activation by p2lnck5a is that p25Y is capable of binding 
to Cdk5 at the activation site. This binding is of a high affinity, 
similar to that of the association between Cdk5 and p2lnck5a. 
To demonstrate the high affinity binding of Cdk5 to p25Y, a 
sample of GST-p25Y was incubated with partially purified 
Cdk5 monomer from bovine brain, followed by affinity-precip- 
itation of GST-p25Y by GSH beads. Western immunoblot 
analysis of the precipitate using three antibodies known to react 
with Cdk5 showed that Cdk5 coprecipitated with GST-p25Y. 
No Cdk5 was detected in the control samples where bacterial 
expressed GST was used instead of the GST-p25Y in the incu- 
bation (Fig. 3). 
In summary, we have identified and cloned a protein frag- 
ment from the putative 143.8 kDa yeast protein which con- 
taines a region homologous to the recently discovered neu- 
ronal-specific Cdk5 activator. Although the similarity between 
the yeast protein and the two nck5a’s is relatively low, a small 
region containing most of the 17-residue sequence in nck5a and 
nck5ai that is the only region displaying homology to the con- 
sensus sequence of cyclins has much higher degree of similarity 
to the yeast protein. A recombinant protein fragment of the 
yeast ORF containing the region equivalent to the 21 kDa 
activation domain of p35nck5a showed high affinity and spe- 
cific association with Cdk5. These results suggest that the puta- 
tive yeast protein may be functionally related to nck5a and 
nck5ai. We have recently suggested that the nck5a defines a 
new family of protein kinase activator, the putative yeast pro- 
tein may be a member of this protein family. 
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